Biotech

All Articles

Cognition's period 2 sparkle information stain Alzheimer's prospect

.Cognition Rehabs' phase 2 sparkle trial has taken a few of the radiance off the Alzheimer's disease...

BMS axes bispecific months after filing to work stage 3 test

.Bristol Myers Squibb has possessed a whiplash change of mind on its BCMA bispecific T-cell engager,...

Charles Baum takes over Terremoto as CEO

.Charles Baum, M.D., Ph.D., that looked after Mirati Therapies' $ 5.8 billion sale to Bristol Myers ...

Asarina to close after efforts to partner Tourette's medicine fail

.After communicating to greater than 200 companies to companion a Tourette syndrome therapy that sho...

Novartis markers $150M upfront bispecifics manage Dren Biography

.Novartis has possessed some bad luck along with bispecific antibodies previously, yet evaluating by...

AstraZeneca vegetations an EGFR tree with Pinetree offer worth $45M

.Pinetree Therapies will aid AstraZeneca plant some trees in its pipe along with a brand-new treaty ...

GRO collects $60M collection B to take gout therapy in to facility

.GRO Biosciences has actually finished the week with an added $60.3 million in the banking company, ...

Chutes &amp Ladders-- Gilead's Merdad Parsey goes, Cassava drops chief executive officer

.Accept to recently's Chutes &amp Ladders, our roundup of substantial management hirings, shootings ...